More tools:
Markets
·
Screener
·
Research
·
Chat
Turn Therapeutics Inc. Common Stock (TTRX) Financial Statements
Turn Therapeutics Inc. Common Stock
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG002QTLH84
XNAS · usd
13.75
▲ 1.09 (8.61%)
As of 2026-09-09
1M
6M
1Y
Valuation
Market Cap
$409.6M
Enterprise Value
—
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
—
EBITDA
—
Diluted EPS (TTM)
—
EBITDA Margin
—
Net Debt
—
Trading Information
Previous Close
12.66
Day's Range
12.58 – 14.39
52-Week Range
2.57 – 26.50
Volume
276.9K
Avg Volume
71.7K
Share Statistics
Shares Outstanding
29.8M
Employees
2
Exchange
XNAS
Listed
2025-10-08
Share count as of August 12, 2026
View
Income Statement
Balance Sheet
Cash Flow
Key Metrics
Valuation
Comparable Companies
Notes & Facts
DCF Model
Earnings Calls
Guidance
Presentations
Detail
Standard
Detailed
Period
Annual
Quarterly
TTM
Loading Income Statement…
Key questions about Turn Therapeutics Inc. Common Stock (TTRX)
What is Turn Therapeutics Inc. Common Stock's Market Cap?
Turn Therapeutics Inc. Common Stock's Market Cap is $409.6M, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Subscribe
Income Statement
(in thousands of USD, except per-share data)
Source: Akyla.ai
Line Item
Jun 30, 2026
Mar 31, 2026
Dec 31, 2025
Sep 30, 2025
Jun 30, 2025
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Operating expenses:
General and administrative
1,153.0
1,136.7
2,158.6
1,754.9
Research and development
475.1
109.4
34.9
158.7
Total operating expenses
1,628.1
1,246.1
2,193.6
1,913.6
Loss from operations
(1,628.1)
(1,246.1)
(2,193.6)
(1,913.6)
Other income (expense):
Net loss from change in fair value of derivative liability instrument
(3,341.6)
697.6
—
—
NET LOSS
(5,849.7)
(971.0)
279.1
(1,904.2)
Basic net loss per common share
(0.20)
(0.03)
0.01
(0.07)
Diluted net loss per common share
(0.20)
(0.03)
0.01
(0.07)